Items Tagged ‘Richard Weinshilboum’
September 8, 2021
Genetic variants influence migraine treatment response, according to new Mayo study
By Susan Murphy 
Migraines affect nearly 40 million people in the U.S. Yet pinpointing an effective prophylactic medication ― the most commonly prescribed drugs for people diagnosed with migraines ― remains a long and complex process. Patients often cycle through medications for weeks or months until achieving a therapeutic response. Now after years of slow progress in migraine therapies […]
Tags: Center for Individualized Medicine, Fred Cutrer, genetics, migraine, neurology, personalized medicine, pharmacogenomics, Richard Weinshilboum
March 22, 2021
Mayo Clinic Research in the news — 3/22/2021
News including Mayo Clinic research and research expertise this week covered a wide range of topics, including genetic testing to inform prescribing blood thinners and therapies for bile duct and gall bladder cancers. A number of women’s health related articles highlighted Mayo Clinic research, there were some arguments for naps, and the ever present COVID-19 […]
Tags: antiplatelet, asthma, bile duct cancer, breast cancer, COVID-19, Diego Zaquera Carvalho, Elizabeth Stewart, gall bladder cancer, gastroenterology, genetic testing, genetics, genomics
September 4, 2019
Mayo experts provide insights into how genes affect medication response
By Advancing the Science contributor
By Sharon Rosen Pharmacogenomics – how a person’s genes affect medication response – is touching virtually every area of medical care. Findings from the Mayo Clinic RIGHT study (Right Drug, Right Dose, Right Time–Using Genomic Data to Individualize Treatment) showed that 99% of participants had at least one genetic variant that may affect their response […]
Tags: breast cancer, cancer, cancer genomics, Center for Individualized Medicine, Eric Matey, Lauren Cornell, mental health, Michael Shuh, neurology, opioids, pharmacogenomics, pharmacy
July 24, 2019
Taking the guesswork out of finding the right depression therapy: Meet William Bobo, M.D.
By Advancing the Science contributor
By Sharon Rosen Depression can touch every aspect of a person’s life – affecting the way they think, feel and behave. It is also the leading medical condition for those who complete suicide. Getting the right therapy is crucial. But for patients suffering from the disorder, finding an effective treatment often involves trial and error. […]
Tags: Arjun Athreya, artificial intelligence, Center for Individualized Medicine, genomics, Liewei Wang, mental health, psychiatry, Richard Weinshilboum, University of Illinois Urbana-Champaign, William Bobo
November 6, 2018
This article originally appeared on the Center for Individualized Medicine blog on Oct. 23, 2018. Mayo Clinic research is bringing together knowledge of psychiatry, genetics, metabolomics, pharmacogenomics and artificial intelligence to seek biological markers associated with alcohol use disorder and treatment response. Finding the molecular drivers of alcohol use disorder commonly known as alcoholism, could […]
Tags: Center for Individualized Medicine, Mark Frye, pharmacogenomics, Richard Weinshilboum
September 17, 2018
CIMCON18 — How genomics discovery is transforming individualized care and the path forward
This article originally appeared on the Center for Individualized Medicine blog on Sept. 17, 2018. Article by Sharon Rosen Mining information deeper than genomics, understanding factors linked to disease, analyzing big data, and addressing the challenges of bringing all this information together to advance patient care – these were some of the themes featured at […]
Tags: All of Us, Center for Individualized Medicine, Eric Green, Individualizing Medicine Conference, Keith Stewart, Richard Weinshilboum
August 14, 2018
Research suggests genetics are key in treating night sweats
By Advancing the Science contributor
This post originally was published on the Center for Individualized Medicine blog on June 25, 2018 Article by Heather Carlson Women going through menopause know all too well the discomfort associated with night sweats. Hormone therapy is often used to prevent night sweats. But finding the right dose of estrogen can be tricky, with some […]
Tags: Ann Moyer, Center for Individualized Medicine, genomics, menopause, pharmacogenomics, Richard Weinshilboum, Virginia Miller, women's health
May 24, 2018
Mayo’s RIGHT 10K – moving pharmacogenomics into everyday clinical practice
This article originally appeared on the Center for Individualized Medicine blog on March 20, 2018. By Sharon Rosen After nearly half a century of research, Mayo Clinic is a leader in moving pharmacogenomics into clinical practice. This year pharmacogenomics test results for 10,000 Mayo Clinic patients, all participants in the RIGHT 10K study, are being added […]
Tags: biobank, Center for Individualized Medicine, DNA testing, genetics, Paul Takahashi, pharmacogenomics, Richard Weinshilboum
August 25, 2015
Sharing Research In Our Community
Mayo Clinic’s three transformational centers – the Center for the Science of Health Care Delivery, the Center for Regenerative Medicine, and the Center for Individualized Medicine have joined forces in collaboration with Madonna Living Community in the development of a speaker series for their residents as well as members of the community. Meeting bi-monthly, Mayo […]
Tags: Center for Individualized Medicine, Center for the Science of Health Care Delivery, collaboration, David Eton, Madonna Living Communities, patient reported outcomes, quality of life, Richard Weinshilboum